• Sep 15, 2026

  $263.04+0.49%

• Sep 14, 2026

  $261.77+1.81%

  Comparable pharmaceutical preparations companies rose 0.81% on average that day, with all of the six tracked names gaining [1], a smaller move than ABbVie's advance.

  • 1Peer group

• Sep 11, 2026

  $257.12+0.83%

• Sep 10, 2026

  $255.00+1.63%

  AbbVie's board declared a quarterly cash dividend of $1.73 per share [1]. Comparable pharmaceutical companies fell 0.93% on average that day, with all six peers listed declining, so AbbVie's 1.63% gain was not shared by that group [2].

  • 1Pr Newswire
  • 2Peer group

• Sep 9, 2026

  $250.91+0.86%

• Sep 8, 2026

  $248.78-2.99%

  Comparable pharmaceutical companies fell 2.29% on average [1], with all six names in the group declining, and ABBV's decline was in line with that move [1].

  • 1Peer group

• Sep 4, 2026

  $256.46-1.44%

  AbbVie shares fell 1.44%, a decline that came alongside a broader drop among comparable pharmaceutical companies, which fell 1.19% on average that day [1].

  • 1Peer group

Closing prices for ABBV. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.